Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 11:48 PM
Ignite Modification Date:
2025-12-25 @ 9:42 PM
NCT ID:
NCT02787551
Pre Assignment Details:
A total of 514 participants were randomized in 1:1 (Insulin Glargine/Lixisenatide fixed ratio combination \[FRC\] or glucagon-like peptide-1 receptor agonist \[GLP-1 RA\]) ratio. Randomization was stratified by values of HbA1c at screening (\<8%, \>=8%) \& GLP-1 RA subtype at screening (once/twice daily \[QD/BID\], once weekly \[QW\] formulations).
Recruitment Details:
The study was conducted at 112 sites in 9 countries. A total of 840 participants were screened between 06 July 2016 and 01 November 2017, of which 326 were screen failures. Screen failures were mainly due to glycated hemoglobin (HbA1c) level lesser than (\<)7% or more than (\>)9% at screening visit.
Study:
NCT02787551
Study Brief:
Results Section:
NCT02787551